Pilot Phase IIa Study of Metronomic Chemotherapy With Taxotere (Docetaxel) Plus Nexavar (Sorafenib) as First-Line Therapy in Performance Status-2 Patients With Advanced Non-Squamous Cell Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 23 May 2017
At a glance
- Drugs Docetaxel; Sorafenib
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Jun 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 24 Jan 2012 Actual patients number is 5 as reported by ClinicalTrials.gov.
- 24 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.